logo
Bull market enters the 'anything goes' phase. Should you follow?

Bull market enters the 'anything goes' phase. Should you follow?

CNBC3 days ago
"Hey, you never know" was the catchphrase of New York State Lottery ads through much of the 1990s. An old friend in advertising who worked on another state's lottery account once told me his creative team couldn't get that line out of their minds, failing to improve upon the way it so perfectly captured the awareness of long odds that make the notion of winning that much more enticing. "I'll probably lose – but what if I don't?" Without belaboring a clumsy and reductionist analogy between negative-sum lottery games and positive-sum investing, the recent re-embrace of meme-stock trading, proliferating short-squeeze stampedes and the alt-coin crypto revival has that "Hey, you never know" flavor. And, frankly, the thing about markets is you truly never do know what stocks will work, or why, or how much good or bad news is priced in at a given moment. The best professional investors of all time get it right maybe 55% of the time, so why wouldn't amateurs shoot for low-probability/high-payout bets? We've already been citing the rushing torrent of speculative adrenaline in racier, gamier stocks for weeks, and now we appear firmly in the "Anything goes" phase of this bull market. The question is whether to view this outbreak of frothy fun as a warning that the broader market has grown euphorically risky, or as a sort of "rationally reckless" impulse that can help energize an otherwise sturdy and poised bull market. An enormous proportion of last week's trading volume was in zombie 2021-era busted momentum plays such as OpenDoor and GoPro , along with heavily shorted household names Kohl's and Krispy Kreme . Last week JPMorgan calculated that the investor crowding into the most volatile and often lower-quality "high-beta" stocks has essentially never been more extreme over the past 35 years. The firm is also tracking retail-trader buying in high-short-interest stocks, now showing its sixth frenzied outburst since 2020. Such excitement has quickly drawn the tut-tutting of the spoilsports and voices of moderation, though I tend not to scold those playing these games. For one thing, this is a lot closer to how Wall Street started – a game of telephone among pods of speculators before the invention of the telephone – than is represented in any academic version of sober capital formation. For another, how would one expect profit-motivated, low-information traders to behave after the S & P 500 has been compounding at a 115% annual pace since April 7 and the Goldman Sachs basket of retail-favorite stocks is up 50% over that time? It's possible for this activity to be both foolhardy for those participating and not particularly dangerous to the broader $60 trillion in U.S. market capitalization. It's likely, for one thing, that many of those involved are in on the joke, to a large degree. They perhaps see a surge in social attention toward certain tickers or identify asymmetric advantage in stocks burdened by many complacent short sellers. Most will lose money and many will lose interest, and that's ultimately how many buy-and-hold index investors are born. Measuring the speculation surge One thing for sure, this overheated activity is motivating market researchers to devise new, better-tuned analytical thermometers to measure it. Goldman last week introduced a Speculative Trading Indicator based that's now in its sharpest three-month upswing ever outside the late-1990s tech mania and the original meme-stock/SPAC fever of 2020-2021. The indicator captures trading volumes in penny stocks, unprofitable companies and those with the most extreme valuations. Volume in penny stocks is now running in the 98 th percentile of all periods since 1990, and turnover in stocks with enterprise-value-to-sales ratios above 10 is in the 96 th , the firm says. (This harkens to a known lottery phenomenon called "jackpot fatigue" – a given level of payout fails to excite players after a while, requiring more juice to activate their interest.) Fascinatingly, similar rushes for the risky fringe of the markets have in the past had positive implications for S & P 500 returns over the ensuing 3-, 6- and 12-month periods, Goldman says, but beyond a year they have tended to lead to significantly worse performance. "The trend is your friend until the end when it bends," indeed. 3Fourteen Research co-founder and CIO Warren Pies unveiled a new Daily Sentiment Composite last week as well, comprising ETF flows, options activity, systematic-hedge-fund behavior, surveys and more. It's now above 70 on its zero-to-100 scale, with 60 being the threshold for "excessive optimism." This dampens the outlook for market returns while the composite stays in the upper range. Pies, who is holding to a 6,800 year-end S & P target, nonetheless expects a tougher couple of months from here due to less demand from "automatic buyers" (corporate buybacks and volatility-targeting hedge funds); weaker seasonal patterns; potential cracks in the economic-growth narrative; and the aforementioned sentiment setup. Pies also goes deep on the broad-scale, society-wide "fear of losing ground" to the acceleration in assets that have run higher on what he calls "debasement" forces – persistent fiscal deficits and political pressure to lower interest rates that are benefiting stocks, real estate, crypto and gold, while undercutting housing affordability and lifting longer-term market-based inflation expectations. "In this new world, an increasingly large number of (particularly young) citizens believe that leveraged speculation is the only way to break out of the American caste system. It is no surprise that online gambling has boomed in this new era," he says. "It is hard to blame the young speculators who have embraced financial nihilism." It's common for financial-wellness types to lament the way consumers of modest means spend on lottery tickets (more than $300 a year per capita in states that have lotteries), when they could build a cushion more safely by saving that money. But research shows that saving such sums is rarely enough to materially change a person's financial reality, whereas the longshot windfall could. Similarly, we can talk to young people who trade short-dated stock options or leveraged ETFs or penny stocks about the power of long-term compounding and clockwork retirement contributions, but good luck having it penetrate when homes are out of reach for most and we've just seen trillions in crypto wealth pile up in a few years, as bitcoin was all the while derided (with good reason) as economically unnecessary. Financial guardrails being removed These are tidal shifts in societal behavior lapping around the edges of the capital markets. There's a broader story to tell these days about the urgent removal of financial guardrails and the gradual buildup of structural excesses now underway: Congress is greenlighting stablecoins and blessing crypto-ownership expansions. Banks are being urged to lend to consumers against their crypto assets. Robinhood is tokenizing high-value private startups to let smaller investors own them. Regulators are reportedly close to lowering minimum-balance levels for so-called "pattern day traders" while opening 401(k) plans to alternative assets. The AI buildout boom is taking on financial leverage, with Meta Platforms and xAI tapping private credit to build data centers. Advocates for such measures can surely argue that the removal of frictional barriers is beneficial to enabling capital flows among risk takers, perhaps raising the economy's metabolism. Still, it's tough to make the case that U.S. capital markets – featuring the deepest credit markets and the world's most stoutly valued equity indexes – have been stymied all that much by bureaucratic overreach. The peddlers of prudence will no doubt eventually find something in all this to say "I told you so" about, but who knows when. The implications will likely emerge sporadically over a span of years and are not particularly useful for handicapping the market's immediate prospects from here. It remains notable that for all the wild action in the spicier parts of the market, the core of the equity complex has scarcely made a misstep in months. The furious springtime rebound rally has given way to a calm, low-drama grind – a "boring is bullish" mode. The S & P 500 was nearly static on multiple days last week, reflecting some groups cooling off and others playing some catch-up, a so-far orderly rotation that nonetheless bears monitoring. The benefit of the doubt remains with the bullish overall trend, even while the case for a tactical pause or retrenchment builds. Stock reactions to earnings have been slightly net negative for the companies reporting even as the aggregate "beat rate" has been expectedly high. The Nasdaq 100 is getting pretty stretched relative to its longer-term trend and has put in a significant multi-month peak in the second half of July the past two years. Arguably, the consensus is now a bit complacent regarding the potential impact of tariff outcomes, lulled by a slow-and-steady economy helped by a torrid tech capex binge. Valuation is not much of a tactical help, but I'll note that Microsoft – an excellent measuring tool given it's been near the top of the index and at the front lines of tech trends for more than a generation – is again trading above 33-times forward 12-month earnings. Its P/E has been no higher than 34 since the early 2000s, all in the past few years. Elevated, sure, and reflective of a market pricing in plenty of positives. But not exactly bubbly – the stock traded above 50x in the two years before the March 2000 peak of the tech mania, a time when the public intoxication with risk reached genuine historic extremes that the current speculative wave has not yet even closely approached.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Stock market today: S&P 500, Nasdaq rise as earnings flood in, jobs data on deck
Stock market today: S&P 500, Nasdaq rise as earnings flood in, jobs data on deck

Yahoo

time7 minutes ago

  • Yahoo

Stock market today: S&P 500, Nasdaq rise as earnings flood in, jobs data on deck

US stocks moved higher on Tuesday, eyeing a bid for more records as investors combed through a fresh rush of corporate earnings and waited for key economic data in a big week on Wall Street. The S&P 500 (^GSPC) rose 0.2% on the heels of narrowly notching a sixth all-time closing high in a row, while the tech-heavy Nasdaq Composite (^IXIC) led the way higher with a 0.4% gain. The Dow Jones Industrial Average (^DJI) was roughly flat. The mood is modestly upbeat as a blockbuster week for markets gets into full swing. The Federal Reserve kicks off its two-day policy meeting on Tuesday, while the JOLTS job openings update for June due later ushers in a series of crucial labor data culminating in Friday's nonfarm payrolls report. Meanwhile, earnings take center stage as before-the-bell reports from Spotify (SPOT), Merck (MRK), and UnitedHealth (UNH) disappointed Wall Street. Some news were better than others: Boeing (BA) shares lifted as the world's largest planemaker's quarterly results topped expectations. After the bell Tuesday, Starbucks (SBUX) earnings will be scrutinized for signs of turnaround progress and of the impact of tariffs. The wave of earnings Tuesday will help set the tone for this week's highlights: results from tech giants Apple (AAPL), Amazon (AMZN), Microsoft (MSFT), and Meta (META). Read more: Full earnings coverage in our live blog Also looming large is President Trump's deadline Friday for trading partners to strike deals or face blanket tariff rates. The Commerce Department's Census Bureau on Tuesday reported a sharp decline in the US goods trade deficit in June as businesses looked to get ahead of tariffs. Hopes for an extension to the US-China trade truce are buoying the likes of AI chipmaker Nvidia's (NVDA) stock. Read more: The latest on Trump's tariffs Trade war fears may have lost their grip on markets, given the S&P 500 (^GSPC) and Nasdaq Composite (^IXIC) only barely managed new records on Monday despite a new US-EU trade deal. On Tuesday's economic docket, Conference Board's July reading on consumer confidence and a S&P CoreLogic print on home prices in May provide a health check on the economy ahead of an update on second quarter GDP later this week, P&G dips as it warns of $1 billion tariff hit Procter & Gamble (PG) stock dipped about 1%, reversing a slight premarket gain, as the company took a cautious approach with its financial outlook while it navigates uncertain consumer sentiment and Trump's tariffs. Yahoo Finance's Brian Sozzi reports: Read the full story here. Tech leads stocks higher at the open The tech-heavy Nasdaq Composite (^IXIC) led US stocks higher at the open on Tuesday morning with a 0.5% gain. Meanwhile, the S&P 500 (^GSPC) rose 0.2% on the heels of notching a sixth all-time closing high in a row on Monday. The Dow Jones Industrial Average (^DJI) opened roughly flat. Investors are digesting a wave of earnings reports and US trade data showing a sharp narrowing in the deficit (as tariffs loom). Meanwhile, they are looking ahead to the JOLTS job openings update for June at 10 a.m. ET. for labor market insight. Major drugmakers mixed amid earnings Of the notable drugmakers reporting earnings Tuesday, AstraZeneca rose almost 2% and Merck fell nearly 4% before the market open. British drugmaker AstraZeneca reported second quarter revenue ahead of expectations Tuesday, with its cancer drugs helping fuel sales for the period. Meanwhile, fellow pharma giant Merck reported earnings below Wall Street's projections, according to Bloomberg consensus data, and revenue from its HPV vaccine Gardasil was also less than expected amid continued headwinds in China. Investors are also bracing for patents for its drug Keytruda (which accounted for roughly half of its second quarter revenue) to expire in 2028. Also on Tuesday, Danish drugmaker Novo Nordisk (NVO) plummeted roughly 20%. The firm cut its 2025 revenue and profit outlook, pointing to lower than expected sales growth of its obesity drug Wegovy in the US, ahead of its second quarter earnings results slated for Aug. 6. Trump's DOJ puts companies on notice: Don't evade tariffs The Justice Department is putting American companies on notice that they could be prosecuted if they chose to evade President Trump's tariffs, even as the legality of the president's "Liberation Day" duties remain unsettled in US courts. Yahoo Finance's Alexis Keenan reports: Read more here. Nvidia leads Mag 7 higher on sign of 'enormous pent-up demand' from China Nvidia (NVDA) led the Big Tech "Magnificent Seven" stocks higher on Tuesday before the market open, climbing 1.4%. The gain came after Reuters reported that the AI chipmaker had ordered 300,000 H20 chips from its contract manufacturer TSMC. "This supports our theory that there is enormous pent-up demand for NVDA chips from China right now," Hedgeye Risk Management analyst Felix Wang wrote in a note to clients. Meanwhile, Microsoft (MSFT), Meta (META), and Amazon (AMZN) rose fractionally ahead of their quarterly earnings reports later this week. Apple (AAPL), Google (GOOG), and Tesla (TSLA) traded down less than 1%. Good morning. Here's what's happening today. Economic data: S&P CoreLogic 20-city home price index (May); Conference Board consumer confidence, July; Job Openings and Labor Turnover Survey (June); Dallas Fed services activity (July) Earnings: Boeing (BA), Booking Holdings (BKNG), Caesars (CZR), Cheesecake Factory (CAKE), Merck (MRK), PayPal (PYPL), Procter & Gamble (PG), Spotify (SPOT), Starbucks (SBUX), SoFi (SOFI), UnitedHealth Group (UNH), UPS (UPS), Visa (V) Here are some of the biggest stories you may have missed overnight and early this morning: The market is finally getting what it wants 35 charts explain markets and the economy right now UnitedHealth stock falls after reporting mixed Q2 earnings Sarepta stock soars as FDA reverses course on gene therapy pause Spotify stock slides after Q2 earnings and revenue miss Trump's DOJ puts companies on notice on tariffs US, EU rush to clinch final details and lock in trade deal Apple to Shutter a Retail Store in China for the First Time Ever Stellantis faces $1.7B hit from US tariffs this year Trending tickers: UPS, Whilepool and Royal Caribbean Here are some top stocks trending on Yahoo Finance in premarket trading: UPS (UPS) stock fell over 2% before the bell on Tuesday after reporting a drop in second-quarter profit and revenue, as demand took a hit from new "de minimis" tariffs on low-value Chinese shipments and mounting risks from President Donald Trump's trade policies. Whirlpool (WHR) stock fell premarket on Tuesday. after the appliance maker slashed its earnings outlook the day prior. Royal Caribbean (RCL) stock rose 4% before the bell after raising its annual profit forecast on Tuesday, banking on resilient demand for the cruise operator's high-end private island destinations and premium sailings. The market is finally getting what it wants Wall Street's busiest week of the summer is turning out to be an inflection point. Yahoo Finance's Hamza Shaban explains why in today's Morning Brief: Read more here. Spotify stock sinks after Q2 earnings miss Spotify (SPOT) shares fell as much as 10% in early premarket trading Tuesday after the company missed second quarter earnings and revenue expectations. The results follow a remarkable 120% rally over the past year, as the stock rebounded from 2022 lows on the back of price hikes, cost cuts, and investor enthusiasm for AI and advertising. Spotify hit a record high of $738.45 earlier this month, but shares slid to around $635 immediately following the results. Spotify reported second quarter revenue of €4.19 billion ($4.86 billion), missing analyst expectations of €4.27 billion, though up from €3.81 billion in the same period last year. The company posted an adjusted loss of €0.42 ($0.49) per share, sharply missing forecasts for a profit of €1.97 and down from earnings of €1.33 in Q2 2024. "Outsized currency movements during the quarter impacted reported revenue by €104 million vs. guidance," the company said in the earnings release. Operating income also fell short of expectations in the quarter, though subscriber metrics for both premium and ad-supported tiers came in ahead of estimates. Gross margins of 31.5% came in as expected. Spotify's massive rally heading into the earnings report was fueled by a sweeping business overhaul, including layoffs, leadership changes, and a pullback from costly podcast exclusivity. After spending $1 billion to build out its podcast business, the company has since scaled back and narrowed its focus. Still, it remains committed to the medium, paying over $100 million to creators in Q1 alone, including high-profile names like Joe Rogan and Alex Cooper. Read more here. UnitedHealth stock slips after mixed Q2 results Shares of UnitedHealth Group (UNH) fell nearly 3% after its quarterly results before the bell painted a mixed picture. Yahoo Finance's Anjalee Khemlani reports: Read more here. Sarepta stock rockets higher after FDA greenlight Shares in drugmaker Sarepta (SRPT) rocketed up over 30% in premarket after the embattled company got the FDA's go-ahead to resume shipments of its Elevdis gene therapy. The greenlight comes after Sarepta put a voluntary pause on shipments for some patients while the US regulator reviewed its safety following deaths. The FDA on Monday recommended that the compa lift that halt. Sarepta's stock is poised to build on a 16% gain on Monday, continuing a recent volatile spell triggered by changing fortunes for its best-selling product. AP reports: Read more here. Nvidia orders 300,000 H20 chips from TSMC to satiate Chinese demand Reuters reports: Nvidia placed orders for 300,000 H20 chipsets with contract manufacturer TSMC last week, two sources said, with one of them adding that strong Chinese demand had led the U.S. firm to change its mind about just relying on its existing stockpile. Read more here. Oil maintains gains with tariffs and OPEC+ supply in sight Oil maintained gains following Trump putting pressure on Russia over the war in Ukraine with economic sanctions against Putin's government on the table. Bloomberg reports: Read more here. P&G dips as it warns of $1 billion tariff hit Procter & Gamble (PG) stock dipped about 1%, reversing a slight premarket gain, as the company took a cautious approach with its financial outlook while it navigates uncertain consumer sentiment and Trump's tariffs. Yahoo Finance's Brian Sozzi reports: Read the full story here. Procter & Gamble (PG) stock dipped about 1%, reversing a slight premarket gain, as the company took a cautious approach with its financial outlook while it navigates uncertain consumer sentiment and Trump's tariffs. Yahoo Finance's Brian Sozzi reports: Read the full story here. Tech leads stocks higher at the open The tech-heavy Nasdaq Composite (^IXIC) led US stocks higher at the open on Tuesday morning with a 0.5% gain. Meanwhile, the S&P 500 (^GSPC) rose 0.2% on the heels of notching a sixth all-time closing high in a row on Monday. The Dow Jones Industrial Average (^DJI) opened roughly flat. Investors are digesting a wave of earnings reports and US trade data showing a sharp narrowing in the deficit (as tariffs loom). Meanwhile, they are looking ahead to the JOLTS job openings update for June at 10 a.m. ET. for labor market insight. The tech-heavy Nasdaq Composite (^IXIC) led US stocks higher at the open on Tuesday morning with a 0.5% gain. Meanwhile, the S&P 500 (^GSPC) rose 0.2% on the heels of notching a sixth all-time closing high in a row on Monday. The Dow Jones Industrial Average (^DJI) opened roughly flat. Investors are digesting a wave of earnings reports and US trade data showing a sharp narrowing in the deficit (as tariffs loom). Meanwhile, they are looking ahead to the JOLTS job openings update for June at 10 a.m. ET. for labor market insight. Major drugmakers mixed amid earnings Of the notable drugmakers reporting earnings Tuesday, AstraZeneca rose almost 2% and Merck fell nearly 4% before the market open. British drugmaker AstraZeneca reported second quarter revenue ahead of expectations Tuesday, with its cancer drugs helping fuel sales for the period. Meanwhile, fellow pharma giant Merck reported earnings below Wall Street's projections, according to Bloomberg consensus data, and revenue from its HPV vaccine Gardasil was also less than expected amid continued headwinds in China. Investors are also bracing for patents for its drug Keytruda (which accounted for roughly half of its second quarter revenue) to expire in 2028. Also on Tuesday, Danish drugmaker Novo Nordisk (NVO) plummeted roughly 20%. The firm cut its 2025 revenue and profit outlook, pointing to lower than expected sales growth of its obesity drug Wegovy in the US, ahead of its second quarter earnings results slated for Aug. 6. Of the notable drugmakers reporting earnings Tuesday, AstraZeneca rose almost 2% and Merck fell nearly 4% before the market open. British drugmaker AstraZeneca reported second quarter revenue ahead of expectations Tuesday, with its cancer drugs helping fuel sales for the period. Meanwhile, fellow pharma giant Merck reported earnings below Wall Street's projections, according to Bloomberg consensus data, and revenue from its HPV vaccine Gardasil was also less than expected amid continued headwinds in China. Investors are also bracing for patents for its drug Keytruda (which accounted for roughly half of its second quarter revenue) to expire in 2028. Also on Tuesday, Danish drugmaker Novo Nordisk (NVO) plummeted roughly 20%. The firm cut its 2025 revenue and profit outlook, pointing to lower than expected sales growth of its obesity drug Wegovy in the US, ahead of its second quarter earnings results slated for Aug. 6. Trump's DOJ puts companies on notice: Don't evade tariffs The Justice Department is putting American companies on notice that they could be prosecuted if they chose to evade President Trump's tariffs, even as the legality of the president's "Liberation Day" duties remain unsettled in US courts. Yahoo Finance's Alexis Keenan reports: Read more here. The Justice Department is putting American companies on notice that they could be prosecuted if they chose to evade President Trump's tariffs, even as the legality of the president's "Liberation Day" duties remain unsettled in US courts. Yahoo Finance's Alexis Keenan reports: Read more here. Nvidia leads Mag 7 higher on sign of 'enormous pent-up demand' from China Nvidia (NVDA) led the Big Tech "Magnificent Seven" stocks higher on Tuesday before the market open, climbing 1.4%. The gain came after Reuters reported that the AI chipmaker had ordered 300,000 H20 chips from its contract manufacturer TSMC. "This supports our theory that there is enormous pent-up demand for NVDA chips from China right now," Hedgeye Risk Management analyst Felix Wang wrote in a note to clients. Meanwhile, Microsoft (MSFT), Meta (META), and Amazon (AMZN) rose fractionally ahead of their quarterly earnings reports later this week. Apple (AAPL), Google (GOOG), and Tesla (TSLA) traded down less than 1%. Nvidia (NVDA) led the Big Tech "Magnificent Seven" stocks higher on Tuesday before the market open, climbing 1.4%. The gain came after Reuters reported that the AI chipmaker had ordered 300,000 H20 chips from its contract manufacturer TSMC. "This supports our theory that there is enormous pent-up demand for NVDA chips from China right now," Hedgeye Risk Management analyst Felix Wang wrote in a note to clients. Meanwhile, Microsoft (MSFT), Meta (META), and Amazon (AMZN) rose fractionally ahead of their quarterly earnings reports later this week. Apple (AAPL), Google (GOOG), and Tesla (TSLA) traded down less than 1%. Good morning. Here's what's happening today. Economic data: S&P CoreLogic 20-city home price index (May); Conference Board consumer confidence, July; Job Openings and Labor Turnover Survey (June); Dallas Fed services activity (July) Earnings: Boeing (BA), Booking Holdings (BKNG), Caesars (CZR), Cheesecake Factory (CAKE), Merck (MRK), PayPal (PYPL), Procter & Gamble (PG), Spotify (SPOT), Starbucks (SBUX), SoFi (SOFI), UnitedHealth Group (UNH), UPS (UPS), Visa (V) Here are some of the biggest stories you may have missed overnight and early this morning: The market is finally getting what it wants 35 charts explain markets and the economy right now UnitedHealth stock falls after reporting mixed Q2 earnings Sarepta stock soars as FDA reverses course on gene therapy pause Spotify stock slides after Q2 earnings and revenue miss Trump's DOJ puts companies on notice on tariffs US, EU rush to clinch final details and lock in trade deal Apple to Shutter a Retail Store in China for the First Time Ever Stellantis faces $1.7B hit from US tariffs this year Economic data: S&P CoreLogic 20-city home price index (May); Conference Board consumer confidence, July; Job Openings and Labor Turnover Survey (June); Dallas Fed services activity (July) Earnings: Boeing (BA), Booking Holdings (BKNG), Caesars (CZR), Cheesecake Factory (CAKE), Merck (MRK), PayPal (PYPL), Procter & Gamble (PG), Spotify (SPOT), Starbucks (SBUX), SoFi (SOFI), UnitedHealth Group (UNH), UPS (UPS), Visa (V) Here are some of the biggest stories you may have missed overnight and early this morning: The market is finally getting what it wants 35 charts explain markets and the economy right now UnitedHealth stock falls after reporting mixed Q2 earnings Sarepta stock soars as FDA reverses course on gene therapy pause Spotify stock slides after Q2 earnings and revenue miss Trump's DOJ puts companies on notice on tariffs US, EU rush to clinch final details and lock in trade deal Apple to Shutter a Retail Store in China for the First Time Ever Stellantis faces $1.7B hit from US tariffs this year Trending tickers: UPS, Whilepool and Royal Caribbean Here are some top stocks trending on Yahoo Finance in premarket trading: UPS (UPS) stock fell over 2% before the bell on Tuesday after reporting a drop in second-quarter profit and revenue, as demand took a hit from new "de minimis" tariffs on low-value Chinese shipments and mounting risks from President Donald Trump's trade policies. Whirlpool (WHR) stock fell premarket on Tuesday. after the appliance maker slashed its earnings outlook the day prior. Royal Caribbean (RCL) stock rose 4% before the bell after raising its annual profit forecast on Tuesday, banking on resilient demand for the cruise operator's high-end private island destinations and premium sailings. Here are some top stocks trending on Yahoo Finance in premarket trading: UPS (UPS) stock fell over 2% before the bell on Tuesday after reporting a drop in second-quarter profit and revenue, as demand took a hit from new "de minimis" tariffs on low-value Chinese shipments and mounting risks from President Donald Trump's trade policies. Whirlpool (WHR) stock fell premarket on Tuesday. after the appliance maker slashed its earnings outlook the day prior. Royal Caribbean (RCL) stock rose 4% before the bell after raising its annual profit forecast on Tuesday, banking on resilient demand for the cruise operator's high-end private island destinations and premium sailings. The market is finally getting what it wants Wall Street's busiest week of the summer is turning out to be an inflection point. Yahoo Finance's Hamza Shaban explains why in today's Morning Brief: Read more here. Wall Street's busiest week of the summer is turning out to be an inflection point. Yahoo Finance's Hamza Shaban explains why in today's Morning Brief: Read more here. Spotify stock sinks after Q2 earnings miss Spotify (SPOT) shares fell as much as 10% in early premarket trading Tuesday after the company missed second quarter earnings and revenue expectations. The results follow a remarkable 120% rally over the past year, as the stock rebounded from 2022 lows on the back of price hikes, cost cuts, and investor enthusiasm for AI and advertising. Spotify hit a record high of $738.45 earlier this month, but shares slid to around $635 immediately following the results. Spotify reported second quarter revenue of €4.19 billion ($4.86 billion), missing analyst expectations of €4.27 billion, though up from €3.81 billion in the same period last year. The company posted an adjusted loss of €0.42 ($0.49) per share, sharply missing forecasts for a profit of €1.97 and down from earnings of €1.33 in Q2 2024. "Outsized currency movements during the quarter impacted reported revenue by €104 million vs. guidance," the company said in the earnings release. Operating income also fell short of expectations in the quarter, though subscriber metrics for both premium and ad-supported tiers came in ahead of estimates. Gross margins of 31.5% came in as expected. Spotify's massive rally heading into the earnings report was fueled by a sweeping business overhaul, including layoffs, leadership changes, and a pullback from costly podcast exclusivity. After spending $1 billion to build out its podcast business, the company has since scaled back and narrowed its focus. Still, it remains committed to the medium, paying over $100 million to creators in Q1 alone, including high-profile names like Joe Rogan and Alex Cooper. Read more here. Spotify (SPOT) shares fell as much as 10% in early premarket trading Tuesday after the company missed second quarter earnings and revenue expectations. The results follow a remarkable 120% rally over the past year, as the stock rebounded from 2022 lows on the back of price hikes, cost cuts, and investor enthusiasm for AI and advertising. Spotify hit a record high of $738.45 earlier this month, but shares slid to around $635 immediately following the results. Spotify reported second quarter revenue of €4.19 billion ($4.86 billion), missing analyst expectations of €4.27 billion, though up from €3.81 billion in the same period last year. The company posted an adjusted loss of €0.42 ($0.49) per share, sharply missing forecasts for a profit of €1.97 and down from earnings of €1.33 in Q2 2024. "Outsized currency movements during the quarter impacted reported revenue by €104 million vs. guidance," the company said in the earnings release. Operating income also fell short of expectations in the quarter, though subscriber metrics for both premium and ad-supported tiers came in ahead of estimates. Gross margins of 31.5% came in as expected. Spotify's massive rally heading into the earnings report was fueled by a sweeping business overhaul, including layoffs, leadership changes, and a pullback from costly podcast exclusivity. After spending $1 billion to build out its podcast business, the company has since scaled back and narrowed its focus. Still, it remains committed to the medium, paying over $100 million to creators in Q1 alone, including high-profile names like Joe Rogan and Alex Cooper. Read more here. UnitedHealth stock slips after mixed Q2 results Shares of UnitedHealth Group (UNH) fell nearly 3% after its quarterly results before the bell painted a mixed picture. Yahoo Finance's Anjalee Khemlani reports: Read more here. Shares of UnitedHealth Group (UNH) fell nearly 3% after its quarterly results before the bell painted a mixed picture. Yahoo Finance's Anjalee Khemlani reports: Read more here. Sarepta stock rockets higher after FDA greenlight Shares in drugmaker Sarepta (SRPT) rocketed up over 30% in premarket after the embattled company got the FDA's go-ahead to resume shipments of its Elevdis gene therapy. The greenlight comes after Sarepta put a voluntary pause on shipments for some patients while the US regulator reviewed its safety following deaths. The FDA on Monday recommended that the compa lift that halt. Sarepta's stock is poised to build on a 16% gain on Monday, continuing a recent volatile spell triggered by changing fortunes for its best-selling product. AP reports: Read more here. Shares in drugmaker Sarepta (SRPT) rocketed up over 30% in premarket after the embattled company got the FDA's go-ahead to resume shipments of its Elevdis gene therapy. The greenlight comes after Sarepta put a voluntary pause on shipments for some patients while the US regulator reviewed its safety following deaths. The FDA on Monday recommended that the compa lift that halt. Sarepta's stock is poised to build on a 16% gain on Monday, continuing a recent volatile spell triggered by changing fortunes for its best-selling product. AP reports: Read more here. Nvidia orders 300,000 H20 chips from TSMC to satiate Chinese demand Reuters reports: Nvidia placed orders for 300,000 H20 chipsets with contract manufacturer TSMC last week, two sources said, with one of them adding that strong Chinese demand had led the U.S. firm to change its mind about just relying on its existing stockpile. Read more here. Reuters reports: Nvidia placed orders for 300,000 H20 chipsets with contract manufacturer TSMC last week, two sources said, with one of them adding that strong Chinese demand had led the U.S. firm to change its mind about just relying on its existing stockpile. Read more here. Oil maintains gains with tariffs and OPEC+ supply in sight Oil maintained gains following Trump putting pressure on Russia over the war in Ukraine with economic sanctions against Putin's government on the table. Bloomberg reports: Read more here. Oil maintained gains following Trump putting pressure on Russia over the war in Ukraine with economic sanctions against Putin's government on the table. Bloomberg reports: Read more here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Earnings Preview: What To Expect From Paychex's Report
Earnings Preview: What To Expect From Paychex's Report

Yahoo

time7 minutes ago

  • Yahoo

Earnings Preview: What To Expect From Paychex's Report

With a market cap of $52.7 billion, Paychex, Inc. (PAYX) is a leading provider of human capital management solutions, specializing in payroll, HR, benefits, and insurance services for small to medium-sized businesses. The company offers a comprehensive suite of customizable services to help businesses efficiently manage their workforce. Analysts project the Rochester, New York-based company to report an adjusted EPS of $1.22 in Q1 2026, a 5.2% growth from $1.16 in the year-ago quarter. The company has exceeded Wall Street's bottom-line estimates in the last four quarters. More News from Barchart Tesla Just Signed a Chip Supply Deal with Samsung. What Does That Mean for TSLA Stock? Dear Microsoft Stock Fans, Mark Your Calendars for Aug. 1 Is Lucid Motors Stock a Buy, Sell, or Hold for July 2025? Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. For fiscal 2026, analysts forecast the payroll processing services expert to report adjusted EPS of $5.46, up 9.6% from $4.98 in fiscal 2025. PAYX stock has increased 16.3% over the past 52 weeks, underperforming the broader S&P 500 Index's ($SPX) 17.1% return and the Industrial Select Sector SPDR Fund's (XLI) 22.3% gain over the same period. Despite Paychex beating Q4 2025 estimates with adjusted EPS of $1.19 and revenue of $1.4 billion, shares tumbled 9.4% on Jun. 25 due to a sharp 11% drop in operating income to $431.1 million and a 700-basis-point decline in operating margin to 30.2%, both missing expectations. Analysts' consensus view on Paychex stock is cautious, with a "Hold" rating overall. Among 16 analysts covering the stock, 14 suggest a "Hold" and two provide a "Strong Sell" rating. As of writing, the stock is trading below the average analyst price target of $151. On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Analysts Say Buy These 3 Most Oversold Dividend Aristocrats
Analysts Say Buy These 3 Most Oversold Dividend Aristocrats

Yahoo

time37 minutes ago

  • Yahoo

Analysts Say Buy These 3 Most Oversold Dividend Aristocrats

Everyone loves a discount - I'm no exception. When it comes to investing, it is not every day that you can get a quality stock at a lower-than-usual price. As an investor who's always been attracted to income, dividend stocks are my go-to choice. The question is, which one do I choose? I prefer consistency, reliability, and consistent growth. That is precisely the reason why I often start my searches with stocks in the Dividend Aristocrats index. These S&P 500-listed companies have consistently increased their dividends for over 25 years, highlighting their ability to thrive amidst any market conditions. More News from Barchart After Surprising Earnings Pop, Should You Buy This High-Yield Dividend Stock? Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. But, as they say, only death and taxes are guaranteed. For Dividend Aristocrats, a single sentence in a report, article, or on social media could send the stock crashing - making it oversold, regardless of the fundamentals - no matter how strong they are. This is exactly where I find opportunities. When a stock hits oversold levels and Wall Street calls it a 'Buy', that gets my attention. In my experience, it could mean that the price action is driven by short-term sentiment rather than the underlying fundamentals. These events often precede a trend reversal, and that's exactly where I want to be positioned before it happens. How I Came Up With The Following Dividend Stocks To come up with today's list, I used Barchart's Stock Screener. I screened for oversold stocks on the Dividend Aristocrats list. We can find oversold stocks using a technical indicator, the 14-day RSI. A reading of under 30 suggests the stock may be oversold, and a reading of over 70 suggests it's overbought. If we combine RSI with analyst ratings, we will get a stronger confirmation in our results. Spoiler: There are no Dividend Aristocrats currently trading in oversold territory. But, stay with me… Annual Dividend Yield: Left Blank 14-Day Relative Strength Index: Less than 40. There were no stocks under 30. Current Analyst Rating: Wall Street's analysts' rating of Moderate to Strong Buy complements RSI, which strengthens the potential bullish direction of the stock. Number of Analysts: 12 or more. A higher number of analysts indicates a stronger consensus and greater confidence. Watchlist: Dividend Aristocrats. I ran the screen and sorted the results according to the lowest Relative Strength Index: While technically none of these Dividend Aristocrats are oversold, these are the most oversold, buy-rated Dividend Aristocrats today. Chubb Ltd (CB) You may not have heard of this company, but Chubb Ltd is the world's largest publicly traded insurance company. Originally known as ACE Limited, Chubb's services encompass everything from auto, home, and travel insurance to specialized coverage, including cyber, marine, aviation, and political risk. The company operates in six segments, including property and casualty, life, health, and crop insurance for individuals and businesses. In its second quarter of 2025 earnings release, Chubb reported sales of 14.8 billion, up 7.2% from the same quarter last year. Net income also rose 35.3% to almost $3 billion. The company pays a forward annual dividend of $3.88, which translates to a yield of roughly 1.46%. CB's 14-day Relative Strength Index is at 32.16%, indicating that it is approaching oversold territory, has weak momentum, and is nearing undervalued territory. CB stock currently has a 'Moderate Buy' rating consensus from 21 Wall Street analysts. Combined with a low RSI, we may be looking at an excellent buying opportunity before it gains momentum. International Business Machines (IBM) International Business Machines, better known as IBM, is a global leader in integrated solutions. The company has strategic partnerships with several tech giants, including Adobe, Microsoft, and Samsung, among others. IBM operates through four segments: Software, Consulting, Infrastructure, and Financing. The company's second-quarter results reported sales of $17 billion, up 8% year-over-year. Its net income also jumped by 20% to $2.2 billion, and it pays a forward annual dividend of $6.72 per share, which translates to a yield of roughly 2.55%. IBM's 14-day Relative Strength Index is at 32.49%. Similar to CB, it is also nearing the oversold territory (which is <30%), which suggests the stock may be undervalued, and a reversal is just around the corner. IBM has a consensus 'Moderate Buy' rating from 21 analysts, suggesting as much as 32.9% upside in the stock over the next year. Brown & Brown (BRO) The last oversold Dividend Aristocrat in this list is Brown & Brown, an insurance products and services company. The company acts as an intermediary between providers and clients, helping them secure insurance coverage through its four segments: retail insurance, national programs, wholesale brokerage, and services segment. Brown & Brown has just released its second-quarter financials, which reported sales of $1.3 billion, representing a 9.1% year-over-year increase. Net income, however, decreased 10.1% to $231 million, which could be attributed to expenses such as employee compensation and benefits, as well as operating expenses. The company pays a forward annual dividend of $0.60, translating to a yield of approximately 0.58%. BRO's 14-day Relative Strength Index is 34.99%, which is still close to being oversold. Let's say it's the least undersold on this list; however, current momentum still indicates pressure on the stock price. Still, the stock has a consensus 'Moderate Buy' among 16 Wall Street analysts with a high target price of $130. This hints at a potential reversal from its current bearish phase, making today a possible entry point for investors looking for a bullish rally. Final Thoughts As they say, buy low and sell high. With that in mind, these are the three most oversold Dividend Aristocrats today. They're also the same companies that have consistently increased their dividends over the past 25 years, highlighting their resilience and ability to overcome short-term market fears. If you're like me, who likes to bottom-pick stable companies, these Dividend Aristocrats are potentially trading at discounted prices and come with reasonable yields. On the date of publication, Rick Orford did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store